A rather odd week in venture, as the biggest rounds were raised by greentech, business travel and charity startups. Of course ...

Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million ...

With a strong track record for identifying diamonds in the rough, Bain Capital Life Sciences (BCLS) has become a powerful ...

Industry insiders hope the Fed’s decision to cut rates for the first time in years will boost biotech investment. But the long-awaited move won’t cure all that ails the sector, others cautioned.

The drop in interest rate is slightly bigger than anticipated and good news for the biotech industry, but little will change ...

The overheating has caused shifting climate conditions and unpredictable extreme weather events, which have combined to make ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Find out more about six immunology companies that have recently raised impressive funds in the biotech industry.

A rare-disease federal incentive program critical to biotech R&D is in jeopardy, writes Leslie Williams, president and CEO of ...

The value of four recent deals exceeds the $3 billion of exit activity in Massachusetts all of last year, a sign that the ...

Located in the Genopole - a biotechnology research hub in Evry, south of Paris - Abolis is a French start-up specialised in the use of micro-organisms. Since its funding in 2014, it has raised 1.1 ...

Explore Estonia’s biotech scene with 7 pioneering companies across Tallinn, Tartu, and beyond, fueled by top science parks ...